文献速递术前评估与围术期医学气道管理

罗库溴铵联合舒更葡糖用于VATS与缩短胸管引流时长相关

Use of rocuronium and sugammadex for video-assisted thoracoscopic surgery is associated with reduced duration of chest tube drainage: a propensity score-matched analysis.
PubMed 文献 · Br J Anaesth · 2022-08-26

该回顾性单中心研究纳入VATS气管插管全麻患者,比较顺阿曲库铵+新斯的明(n=547)与罗库溴铵+舒更葡糖(n=151),倾向性评分匹配各140例。罗库溴铵+舒更葡糖组胸管引流时间更短(2[1-2] vs 2[1-3]天,P=0.049),延迟拔管风险降低63%(OR 0.37,95%CI 0.20-0.67,P=0.005),术后肺不张(P=0.047)和肺实变(P=0.008)发生率更低。

要点

  • 罗库溴铵+舒更葡糖与VATS后胸管引流时间缩短及延迟拔管风险降低相关
  • 该组术后肺不张和肺实变发生率更低
  • 麻醉时长每增加1小时,延迟拔管风险增加1.57倍(95%CI 1.25-1.96)

核心结论

  • VATS全麻中,与顺阿曲库铵+新斯的明相比,罗库溴铵+舒更葡糖与术后延迟拔除胸管、肺不张和肺实变发生率显著降低相关。

研究设计与样本

  • 回顾性单中心研究,纳入VATS气管插管全麻患者,顺阿曲库铵+新斯的明组n=547,罗库溴铵+舒更葡糖组n=151,倾向性评分匹配各140例。
  • 匹配变量为性别、年龄、体重指数和VATS指征,使用定量神经肌肉监测,置入一根24 Fr胸管。

主要发现

  • 罗库溴铵+舒更葡糖组胸管引流时间更短(2[1-2] vs 2[1-3]天,P=0.049)。
  • 延迟拔除胸管风险降低63%(OR 0.37,95%CI 0.20-0.67,P=0.005)。
  • 术后肺不张发生率更低(P=0.047),肺实变发生率更低(P=0.008)。
  • 麻醉时长每增加1小时,延迟拔除胸管风险增加1.57倍(95%CI 1.25-1.96,P=0.005)。

临床怎么用

  • VATS全麻中可考虑选用罗库溴铵联合舒更葡糖进行神经肌肉阻滞与拮抗,以利于术后早期拔除胸管。
  • 应关注麻醉时长对延迟拔管风险的影响,优化麻醉管理以缩短麻醉时间。

局限性

  • 回顾性单中心设计,样本量有限(匹配后每组140例),可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We investigated the influence of different neuromuscular blocking agents and reversal agents during anaesthesia on early removal of chest tube drainage after video-assisted thoracoscopic surgery (VATS). METHODS: This retrospective single-centre study included patients who underwent VATS after tracheal intubation under general anaesthesia. Patients received either cisatracurium and neostigmine (n=547) or rocuronium and sugammadex (n=151). Quantitative neuromuscular monitoring was used and one chest tube (size 24 Fr) was inserted. To reduce potential bias, 140 patients from each group were matched by propensity score for sex, age, body mass index and indication for VATS. Primary outcome was duration of chest tube drainage after surgery. RESULTS: Use of rocuronium and sugammadex was associated with a shorter duration of chest tube drainage (2 [1-2] vs 2 [1-3] days; P=0.049) and a 63% reduction in delayed chest tube removal (odds ratio 0.37; 95% confidence interval [CI]: 0.20-0.67; P=0.005). This group also had a lower incidence of postoperative atelectasis (P=0.047) and consolidation (P=0.008). Each 1 h increase in the duration of anaesthesia was associated with a 1.57-fold increase in the delayed removal of the chest tube (95% CI: 1.25-1.96; P=0.005). CONCLUSIONS: During general anaesthesia for VATS, compared with cisatracurium and neostigmine, use of rocuronium and sugammadex was associated with a significant decrease in the incidence of postoperative delayed removal of the chest tube, atelectasis, and pulmonary consolidation.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Wu EB, Huang SC, Lu HI, et al. Use of rocuronium and sugammadex for video-assisted thoracoscopic surgery is associated with reduced duration of chest tube drainage: a propensity score-matched analysis. Br J Anaesth. 2022. PMID: 36038393. doi:10.1016/j.bja.2022.07.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。